CRTX - Cornerstone Therapeutics Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - CRTX (1145404)
Filing Date
  
Trade Date
  
Tickers
Insider Name
Trade Type
Share Price $
Value Traded $
Officer
   CEO
   CFO
Director
10% Owner
Other
SIC Industry
Sort by
Max Results
Exclude derivative-related
clear
198 results for CRTX - Yahoo - Tradingview - Stocktwits - SEC

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2014-02-03
CRTXChiesi Farmaceutici Spa10%P - Purchase$9.50+11,542,31310,000-100%+$109,651,9740000
D
2014-02-03
CRTXRoberts AlanVP, Scientific AffairsD - Sale to issuer$9.50-80,9470-100%-$768,9970000
2014-02-03
CRTXMcEwan Alastair StuartCFO, TreasurerD - Sale to issuer$9.50-316,4130-100%-$3,005,9240000
D
2014-02-03
CRTXMcBean KennethPresD - Sale to issuer$9.50-83,7050-100%-$795,1980000
D
2014-02-03
CRTXMaetzel AndreasVP, Clinical, RegulatoryD - Sale to issuer$9.50-25,0000-100%-$237,5000000
D
2014-02-03
CRTXFranklin Joshua BVP, Strategy, Bus. Dev.D - Sale to issuer$9.50-45,9440-100%-$436,4680000
D
2014-02-03
CRTXDuarte IRAPrincipal Accounting OfficerD - Sale to issuer$9.50-7,0000-100%-$66,5000000
D
2014-02-03
CRTXCollard Craig ACEOD - Sale to issuer$9.50-1,612,2250-100%-$15,316,1380000
2013-09-15
CRTXMcEwan Alastair StuartCFO, TreasurerA - Grant$0.00+19,172316,413+6%+$00000
2013-08-30
CRTXPowell Andrew Kenneth WilliamEVP, GCD - Sale to issuer$0.00-27,64589,785-24%-$00000
D
2013-05-06
CRTXMaetzel AndreasVP, Clinical, RegulatoryA - Grant$0.00+25,00025,000New+$00000
2013-03-07
CRTXDuarte IRAPrincipal Accounting OfficerA - Grant$0.00+7,0007,000New+$00000
2013-03-05
CRTXPowell Andrew Kenneth WilliamEVP, GCA - Grant$0.00+21,375117,430+22%+$00000
2013-03-05
CRTXFranklin Joshua BVP, Strategy, Bus. Dev.A - Grant$0.00+25,00045,944+119%+$00000
2013-03-05
CRTXRoberts AlanVP, Scientific AffairsA - Grant$0.00+18,37580,947+29%+$00000
2013-03-05
CRTXMcBean KennethPresA - Grant$0.00+40,00083,705+92%+$00000
2013-03-05
CRTXCollard Craig ACEOA - Grant$0.00+45,0001,612,225+3%+$00000
2013-01-17
CRTXMcBean KennethPresF - Tax$5.58-1,21743,705-3%-$6,7910000
2012-11-06
CRTXMcEwan Alastair StuartCFO, TreasurerA - Grant$0.00+50,000297,241+20%+$00000
2012-11-05
CRTXMcBean KennethPresF - Tax$4.85-1,02244,922-2%-$4,9570000
2012-09-10
CRTXPowell Andrew Kenneth WilliamEVP, GCF - Tax$6.27-2,04596,055-2%-$12,8220000
2012-09-06
CRTXMcBean KennethPresF - Tax$6.30-4,05645,944-8%-$25,5530000
D
2012-08-29
CRTXFranklin Joshua BVP, Strategy, Bus. Dev.M - OptEx$3.90+38,63720,944-218%+$150,6840000
D
2012-08-29
CRTXFranklin Joshua BVP, Strategy, Bus. Dev.S - Sale+OE$6.86-38,63720,944-65%-$265,0500000
D
2012-08-24
CRTXFranklin Joshua BVP, Strategy, Bus. Dev.M - OptEx$3.90+24,68820,944-659%+$96,2830000
D
2012-08-24
CRTXFranklin Joshua BVP, Strategy, Bus. Dev.S - Sale+OE$7.01-24,68820,944-54%-$173,0630000
2012-08-22
CRTXMorgus Vincent T.EVP, Finance, CFOF - Tax$7.22-84749,644-2%-$6,1150000
2012-05-28
CRTXFranklin Joshua BVP, Strategy, Bus. Dev.F - Tax$5.04-4,05620,944-16%-$20,4420000
2012-06-19
CRTXMorgus Vincent T.EVP, Finance, CFOF - Tax$5.94-78750,491-2%-$4,6750000
2012-05-25
CRTXRoberts AlanVP, Scientific AffairsF - Tax$5.04-5,67862,572-8%-$28,6170000
2012-04-03
CRTXChiesi Farmaceutici Spa10%P - Purchase$6.25+1,443,91315,687,538+10%+$9,024,4560000
2012-04-03
CRTXCollard Craig ACEO, 10%S - Sale$6.25-1,443,9131,567,225-48%-$9,024,4560000
AM
2012-03-14
CRTXChiesi Farmaceutici Spa10%P - Purchase$6.04+6,80014,243,6250%+$41,0380000
M
2012-03-14
CRTXChiesi Farmaceutici Spa10%P - Purchase$6.04+6,80014,236,8250%+$41,0380000
2012-03-12
CTRXChiesi Farmaceutici Spa10%P - Purchase$5.85+3,40014,236,8250%+$19,8850000
2012-02-01
CRTXMorgus Vincent T.EVP, Finance, CFOF - Tax$6.48-3,72251,278-7%-$24,1190000
2011-12-14
CTRXChiesi Farmaceutici Spa10%A - Grant$5.12+2,10014,233,4250%+$10,7500000
2011-11-29
CTRXChiesi Farmaceutici Spa10%A - Grant$5.06+8,90014,231,3250%+$45,0780000
D
2011-09-06
CRTXMcBean KennethPresA - Grant$0.00+50,00050,000New+$00000
2011-07-15
CRTXPowell Andrew Kenneth WilliamEVP, GCS - Sale$8.63-2,00098,100-2%-$17,2600000
2011-05-26
CRTXRoberts AlanVP, Scientific AffairsS - Sale$7.60-5,85068,250-8%-$44,4600000
2011-04-04
CRTXPowell Andrew Kenneth WilliamEVP, GCS - Sale$6.53-2,000100,100-2%-$13,0600000
D
2011-02-01
CRTXMorgus Vincent T.EVP, Finance, CFOA - Grant$0.00+55,00055,000New+$00000
2011-01-07
CRTXPowell Andrew Kenneth WilliamEVP, GCS - Sale$5.73-2,000102,100-2%-$11,4600000
2010-12-16
CRTXLutz Steven MichaelEVPS - Sale$6.02-65,000262,348-20%-$391,3000000
2010-12-16
CRTXCollard Craig APres, CEO, 10%S - Sale$6.02-385,0003,011,138-11%-$2,317,7000000
2010-12-16
CRTXChiesi Farmaceutici Spa10%A - Grant$6.02+450,00014,222,425+3%+$2,709,0000000
2010-11-01
CRTXPowell Andrew Kenneth WilliamEVP, GCS - Sale$6.28-7,900104,100-7%-$49,6120000
2010-06-01
CRTXFranklin Joshua BVP, Sales, MarketingS - Sale$5.47-4,12945,871-8%-$22,5860000
2009-10-14
CRTXChiesi Farmaceutici Spa10%A - Grant$0.00+269,68413,772,425+2%+$00000
2009-10-30
CRTXPowell Andrew Kenneth WilliamEVP, GCA - Grant$0.00+110,000112,000>999%+$00000
DM
2009-09-10
CRTXFranklin Joshua BVP, Sales, MarketingM - OptEx$3.90+8,10050,000+19%+$31,5900000
DM
2009-09-10
CRTXFranklin Joshua BVP, Sales, MarketingS - Sale+OE$7.54-8,10050,000-14%-$61,0810000
M
2009-09-01
CRTXPrice DavidCFOS - Sale$7.05-150,000175,133-46%-$1,057,2350000
2009-09-02
CRTXDickson BrianChief Medical OfficerS - Sale$6.74-15,0000-100%-$101,1000000
2009-07-28
CRTXLutz Steven MichaelEVPS - Sale$5.50-350,000327,348-52%-$1,925,0000000
2009-07-28
CRTXCornerstone Biopharma Holdings, Ltd.10%S - Sale$5.50-1,250,0001,952,225-39%-$6,875,0000000
2009-07-28
CRTXCollard Craig APres, CEO, 10%S - Sale$5.50-1,250,0003,396,138-27%-$6,875,0000000
2009-06-19
CRTXMcEwan Alastair StuartDirS - Sale$9.00-8,1410-100%-$73,2690000
M
2009-06-12
CRTXMcEwan Alastair StuartDirS - Sale$8.51-46,7048,141-85%-$397,4510000
M
2009-06-10
CRTXMcEwan Alastair StuartDirS - Sale$8.50-7,16554,845-12%-$60,9030000
M
2009-06-05
CRTXMcEwan Alastair StuartDirS - Sale$8.08-57,03162,010-48%-$460,5450000
D
2009-05-29
CRTXDickson BrianChief Medical OfficerM - OptEx$0.43+15,00015,000New+$6,4500000
D
2009-05-28
CRTXFranklin Joshua BVP, Sales, MarketingA - Grant$0.00+50,00050,000New+$00000
D
2009-05-18
CRTXMcEwan Alastair StuartDirM - OptEx$0.43+119,041119,041New+$51,1880000
M
2009-05-14
CRTXTownsend Scott BGC, EVP LEGALS - Sale$6.48-44,972113,043-28%-$291,6350000
2008-11-14
CRTXYoung Jeffrey EFORMER VP FINANCE, CAOF - Tax$3.50-2204,833-4%-$7700000
D
2008-10-31
CRTXBaldwin Chenyqua MicheleVP FinanceA - Grant$0.00+178,562178,562New+$00000
2008-10-31
CRTXPrice DavidCFOA - Grant$0.00+325,133325,133New+$00000
D
2008-10-31
CRTXLutz Steven MichaelEVPA - Grant$0.00+677,348677,348New+$00000
D
2008-10-31
CRTXCollard Craig APres, CEO, 10%A - Grant$0.00+4,646,1387,848,363+145%+$00000
2008-11-03
CRTXTownsend Scott BGC, EVP LEGALA - Grant$0.00+148,722158,015>999%+$00000
2008-10-31
CRTXTownsend Scott BGC, EVP LEGALF - Tax$3.90-193158,0150%-$7530000
2008-10-31
CRTXYoung Jeffrey EFORMER VP FINANCE, CAOF - Tax$3.90-1935,053-4%-$7530000
2008-10-31
CRTXPhillips TrevorFormer Pres, CEOF - Tax$3.90-5078,074-6%-$1,9770000
2008-02-14
CRTXTownsend Scott BGC, SVP LEGALA - Grant$0.00+35,00094,868+58%+$350000
2008-02-14
CRTXKelly Thomas PatrickCFO, SVP Finance, Corp. Dev,A - Grant$0.00+35,00090,700+63%+$350000
2007-12-27
CRTXYoung Jeffrey EVP FINANCE, CAO, TREASURERF - Tax$1.28-4,27052,469-8%-$5,4660000
2007-12-27
CRTXPhillips TrevorCOO, SVP of OperationsF - Tax$1.28-5,59885,824-6%-$7,1650000
2007-12-27
CRTXTownsend Scott BGC, SVP LEGALF - Tax$1.28-4,27059,868-7%-$5,4660000
D
2007-11-05
CRTXPhillips TrevorCOO, SVP of OperationsA - Grant$0.00+50,00091,422+121%+$500000
2007-11-05
CRTXKelly Thomas PatrickCFO, SVP Finance, Corp. Dev,A - Grant$0.00+25,00055,700+81%+$250000
2007-11-05
CRTXTownsend Scott BGC, SVP LEGALA - Grant$0.00+25,00064,138+64%+$250000
2007-11-05
CRTXYoung Jeffrey EVP FINANCE, CAO, TREASURERA - Grant$0.00+25,00056,739+79%+$250000
2007-08-22
CRTXThomas Frank EPres, CEOP - Purchase$2.12+5,00072,033+7%+$10,6200000
2007-08-22
CRTXKelly Thomas PatrickCFO, SVP Finance, Corp. Dev,P - Purchase$2.08+4,00030,700+15%+$8,3200000
D
2007-08-20
CRTXKelly Thomas PatrickCFO, SVP Finance, Corp. Dev,A - Grant$0.00+26,70026,700New+$270000
D
2007-06-25
CRTXPhillips TrevorCOO, SVP of OperationsM - OptEx$0.38+1,38941,422+3%+$5280000
2007-06-14
CRTXTananbaum James BDirS - Sale$2.29-195,7510-100%-$448,6810000
2007-06-13
CRTXThomas Frank EPres, CEOA - Grant$2.24+1,50067,033+2%+$3,3600000
M
2007-06-11
CRTXTananbaum James BDirS - Sale$2.26-363,310195,751-65%-$819,9820000
M
2007-06-06
CRTXTananbaum James BDirS - Sale$2.60-619,794559,061-53%-$1,612,6240000
2007-06-06
CRTXThomas Frank EPres, CEOA - Grant$2.69+1,50065,533+2%+$4,0350000
M
2007-06-01
CRTXTananbaum James BDirS - Sale$2.78-1,102,1671,178,855-48%-$3,060,9080000
2007-06-04
CRTXThomas Frank EPres, CEOA - Grant$2.75+2,00064,033+3%+$5,5000000
2007-05-31
CRTXTownsend Scott BGC, SVP LEGALJ - Other Purchase$1.59+11,43839,138+41%+$18,1860000
2007-05-31
CRTXYoung Jeffrey EVP FINANCE, CAO, TREASURERJ - Other Purchase$1.59+3,03931,739+11%+$4,8320000
2007-05-31
CRTXThomas Frank EPres, CEOJ - Other Purchase$1.59+2,14862,033+4%+$3,4150000
2007-02-13
CRTXEvnin LukeFormer 10% OwnerJ - Other Purchase$0.00+7,2263,853,1020%+$00000
2007-02-13
CRTXGadicke AnsbertFormer 10% OwnerJ - Other Purchase$0.00+1,2043,847,0800%+$00000
2007-02-13
CRTXSteinmetz MichaelFormer 10% OwnerJ - Other Purchase$0.00+7233,846,5990%+$00000
2007-02-13
CRTXWheeler KurtFormer 10% OwnerJ - Other Purchase$0.00+4523,846,3280%+$00000
2007-02-13
CRTXGalakatos NicholasDirJ - Other Purchase$0.00+9633,846,8390%+$00000
2007-02-13
CRTXWalsh Christopher T PhdDirJ - Other Purchase$0.00+32510,991+3%+$00000
2007-02-13
CRTXMpm Bioventures II Qp LPFormer 10% OwnerJ - Other Sale$0.00-1,000,0003,845,876-21%-$00000
2007-02-13
CRTXGalakatos NicholasDirJ - Other Sale$0.00-1,000,0003,845,876-21%-$00000
D
2006-12-27
CRTXThomas Frank EPres, CEOA - Grant$40.00+40,00059,885+201%+$1,600,0000000
D
2006-12-27
CRTXPhillips TrevorCOO, SVP of OperationsA - Grant$35.00+35,00036,833>999%+$1,225,0000000
D
2006-12-27
CRTXHilt Dana CharlesSVP of Clinical Develop., CMOA - Grant$26.70+26,70026,700New+$712,8900000
D
2006-12-27
CRTXTownsend Scott BGC , VP LEGALA - Grant$26.70+26,70027,700>999%+$712,8900000
D
2006-12-27
CRTXYoung Jeffrey EVP FINANCE, CAO, TREASURERA - Grant$26.70+26,70028,700>999%+$712,8900000
2006-11-30
CRTXThomas Frank EPresJ - Other Purchase$1.66+1,88519,885+10%+$3,1290000
2006-08-08
CRTXThomas Frank EPresA - Grant$3.90+4,00018,000+29%+$15,6000000
D
2006-08-09
CRTXPhillips TrevorCOO, SVP of OperationsM - OptEx$1.05+10,5005,033-192%+$11,0250000
DM
2006-08-08
CRTXPhillips TrevorCOO, SVP of OperationsS - Sale+OE$4.01-14,5005,033-74%-$58,2100000
D
2006-04-25
CRTXWarren Howland ShawDirS - Sale+OE$5.24-8,000224,600-3%-$41,9000000
DE
2006-04-06
CRTXWarren Howland ShawDirM - OptEx$1.05+21,356232,600+10%+$22,4240000
2006-03-28
CRTXWarren Howland ShawDirS - Sale$5.02-8,000211,244-4%-$40,1810000
D
2006-03-22
CRTXRubin Paul DPres, CEOM - OptEx$0.38+72,933124,169+142%+$27,7150000
2006-03-14
CRTXWarren Howland ShawDirS - Sale$5.57-8,000219,244-4%-$44,5440000
D
2006-03-06
CRTXPhillips TrevorCOO, SVP of OperationsM - OptEx$1.05+5,0009,033+124%+$5,2500000
D
2006-03-06
CRTXPhillips TrevorCOO, SVP of OperationsS - Sale+OE$6.00-2,5009,033-22%-$15,0010000
2006-02-28
CRTXWarren Howland ShawDirS - Sale$5.42-8,000227,244-3%-$43,3680000
2006-01-24
CRTXWarren Howland ShawDirS - Sale$5.25-8,000235,244-3%-$42,0320000
D
2006-02-01
CRTXPhillips TrevorCOO, SVP of OperationsM - OptEx$1.05+2,5006,533+62%+$2,6250000
D
2006-02-01
CRTXPhillips TrevorCOO, SVP of OperationsS - Sale+OE$6.42-2,5006,533-28%-$16,0500000
2006-01-30
CRTXRubin Paul DPres, CEOS - Sale$6.54-5,00051,236-9%-$32,6880000
2006-01-24
CRTXWarren Howland ShawDirS - Sale$6.29-8,000243,244-3%-$50,3300000
2006-01-17
CRTXRubin Paul DPres, CEOS - Sale$6.70-5,00056,236-8%-$33,4970000
2006-01-10
CRTXWarren Howland ShawDirS - Sale$6.73-8,000251,244-3%-$53,8680000
D
2006-01-03
CRTXRubin Paul DPres, CEOS - Sale+OE$7.12-5,00061,236-8%-$35,6220000
D
2006-01-03
CRTXPhillips TrevorCOO, SVP of OperationsM - OptEx$0.38+3,3336,533+104%+$1,2670000
D
2006-01-03
CRTXPhillips TrevorCOO, SVP of OperationsS - Sale+OE$7.12-1,9446,533-23%-$13,8500000
2005-12-27
CRTXWarren Howland ShawDirS - Sale$6.69-8,000259,244-3%-$53,4890000
D
2005-12-15
CRTXRubin Paul DPres, CEOG - Gift$0.00-2,00066,236-3%-$00000
D
2005-12-15
CRTXRubin Paul DPres, CEOM - OptEx$0.38+2,00066,236+3%+$7600000
D
2005-12-15
CRTXRubin Paul DPres, CEOS - Sale+OE$6.72-5,00066,236-7%-$33,6220000
2005-12-13
CRTXWarren Howland ShawDirS - Sale$6.75-8,000267,244-3%-$53,9600000
2005-12-02
CRTXPhillips TrevorCOO, SVP of OperationsS - Sale$6.26-5,0005,144-49%-$31,3250000
2005-11-30
CRTXRubin Paul DPres, CEOS - Sale$6.43-5,00071,236-7%-$32,1360000
2005-11-22
CRTXWarren Howland ShawDirS - Sale$6.55-8,000275,244-3%-$52,4390000
A
2005-10-31
CRTXRubin Paul DPres, CEOS - Sale$7.01-5,00081,236-6%-$35,0430000
A
2005-10-17
CRTXRubin Paul DPres, CEOS - Sale$8.65-5,00086,236-5%-$43,2670000
2005-11-15
CRTXRubin Paul DPres, CEOS - Sale$6.78-5,00076,236-6%-$33,9220000
2005-11-08
CRTXWarren Howland ShawDirS - Sale$7.55-8,000283,244-3%-$60,4100000
D
2005-11-02
CRTXThomas Frank ECFO, SVP Finance, TreasurerM - OptEx$5.63+1,00014,000+8%+$5,6300000
2005-11-02
CRTXPhillips TrevorCOO, SVP of OperationsS - Sale$6.57-5,00010,144-33%-$32,8730000
2005-10-31
CRTXRubin Paul DPres, CEOS - Sale$7.01-5,00081,236-6%-$35,0430000
2005-10-25
CRTXWarren Howland ShawDirS - Sale$8.66-8,000291,244-3%-$69,2630000
A
2005-10-11
CRTXWarren Howland ShawDirS - Sale$8.50-8,000299,244-3%-$68,0020000
AD
2004-12-17
CRTXWarren Howland ShawDirM - OptEx$1.05+21,356307,244+7%+$22,4240000
D
2003-12-19
CRTXWarren Howland ShawDirG - Gift$0.00-24,000285,888-8%-$00000
D
2004-06-02
CRTXWarren Howland ShawDirP - Purchase$7.00+1,000285,8880%+$7,0000000
2005-10-17
CRTXRubin Paul DPres, CEOS - Sale$8.65-5,00086,236-5%-$43,2670000
2005-10-11
CRTXWarren Howland ShawDirS - Sale$8.50-8,000298,244-3%-$68,0020000
2005-10-03
CRTXPhillips TrevorCOO, SVP of OperationsS - Sale$9.05-5,00015,144-25%-$45,2580000
D
2005-09-19
CRTXFinnegan FrederickSVP of Sales, MarketingM - OptEx$1.05+24,16940,406+149%+$25,3770000
D
2005-09-21
CRTXTownsend Scott BVP OF LEGAL AFFAIRS, SEC.M - OptEx$4.84+1,0001,000New+$4,8400000
2005-09-19
CRTXPhillips TrevorCOO, SVP of OperationsS - Sale$5.90-5,00020,144-20%-$29,5200000
D
2005-09-14
CRTXThomas Frank ECFO, SVP Finance, TreasurerM - OptEx$5.63+1,00013,000+8%+$5,6300000
2005-09-06
CRTXPhillips TrevorCOO, SVP of OperationsG - Gift$0.00-6,40025,144+34%-$00000
A
2005-08-22
CRTXRubin Paul DPres, CEOG - Gift$0.00-19,40091,236-18%-$00000
2005-08-22
CRTXRubin Paul DPres, CEOG - Gift$0.00-19,40091,236+27%-$00000
AD
2004-06-02
CRTXMpm Bioventures II Qp LP10%C - Converted deriv$0.003,941,3304,298,430-48%$00000
AD
2004-06-02
CRTXMpm Bioventures II Qp LP10%P - Purchase$7.00+357,1004,298,430+9%+$2,499,7000000
D
2005-06-20
CRTXAdvanced Technology Ventures VII LP10%P - Purchase$5.48+1,277,3733,176,418+67%+$7,000,0040000
D
2005-06-20
CRTXGeorge JeanDirP - Purchase$5.48+1,277,3733,176,418+67%+$7,000,0040000
D
2005-06-20
CRTXGalakatos NicholasDir, 10%P - Purchase$5.48+547,4464,845,877+13%+$3,000,0040000
D
2005-06-20
CRTXMpm Bioventures II Qp LP10%P - Purchase$5.48+547,4464,845,877+13%+$3,000,0040000
D
2005-06-20
CRTXMiraelli ChristopherDir, 10%P - Purchase$5.48+1,094,8915,153,323+27%+$6,000,0030000
AD
2004-06-02
CRTXMpm Bioventures III Qp LP10%C - Converted deriv$0.003,941,3304,298,430-48%$00000
AD
2004-06-02
CRTXMpm Bioventures III Qp LP10%P - Purchase$7.00+357,1004,298,430+9%+$2,499,7000000
AD
2004-06-02
CRTXGalakatos NicholasDir, 10%C - Converted deriv$0.003,941,3304,298,430-48%$00000
AD
2004-06-02
CRTXGalakatos NicholasDir, 10%P - Purchase$7.00+357,1004,298,430+9%+$2,499,7000000
AD
2004-04-28
CRTXThomas Frank ECFO, SVP Finance, TreasurerM - OptEx$5.63+10,00010,000New+$56,3000000
A
2005-01-25
CRTXThomas Frank ECFO, SVP Finance, TreasurerM - OptEx$5.63+2,00012,000+20%+$11,2600000
D
2005-01-25
CRTXThomas Frank ECFO, SVP Finance, TreasurerM - OptEx$5.63+2,000120,000+2%+$11,2600000
2004-12-22
CRTXRubin Paul DPres, CEOJ - Other Purchase$0.00+10,000150,568-6%+$00000
D
2004-12-17
CRTXWarren Howland ShawDirM - OptEx$1.05+21,356306,244+7%+$22,4240000
D
2004-06-02
CRTXGeorge JeanDir, 10%C - Converted deriv$0.001,904,7591,904,759-50%$00000
AD
2004-06-02
CRTXHealthcare Ventures VI LP10%C - Converted deriv$0.003,701,3324,058,432-48%$00000
AD
2004-06-02
CRTXHealthcare Ventures VI LP10%P - Purchase$7.00+357,1004,058,432+10%+$2,499,7000000
ADM
2004-01-21
CRTXRubin Paul DPres, CEOG - Gift$0.00-164,66264,664-165%-$00000
ADM
2004-01-21
CRTXRubin Paul DPres, CEOM - OptEx$0.40+106,66464,664-254%+$42,7910000
AD
2004-01-09
CRTXPhillips TrevorCOO, VP of Operations, Sec.M - OptEx$0.38+21,94421,944New+$8,2290000
D
2004-06-02
CRTXMedimmune Ventures, Inc.10%C - Converted deriv$0.002,857,1422,857,142-50%$00000
D
2004-06-02
CRTXGeorge JeanDir, 10%C - Converted deriv$0.001,904,7591,904,759-50%$00000
D
2004-06-02
CRTXNewman WalterChief Scientific Officer, VP RC - Converted deriv$0.0010,666185,332-5%$00000
D
2004-06-02
CRTXPhillips TrevorCOO, VP of Operations, Sec.C - Converted deriv$0.003,20025,144-11%$00000
D
2004-06-02
CRTXRubin Paul DPres, CEOC - Converted deriv$0.0092,57099,236-48%$00000
D
2004-06-02
CRTXGalakatos NicholasDir, 10%C - Converted deriv$0.003,941,3304,298,430-48%$00000
D
2004-06-02
CRTXGalakatos NicholasDir, 10%P - Purchase$7.00+357,1004,298,430+9%+$2,499,7000000
D
2004-06-02
CRTXMpm Bioventures III Qp LP10%C - Converted deriv$0.003,941,3304,298,430-48%$00000
D
2004-06-02
CRTXMpm Bioventures III Qp LP10%P - Purchase$7.00+357,1004,298,430+9%+$2,499,7000000
D
2004-06-02
CRTXJohnson & Johnson10%C - Converted deriv$0.001,961,9042,104,704-48%$00000
D
2004-06-02
CRTXJohnson & Johnson10%P - Purchase$7.00+142,8002,104,704+7%+$999,6000000
D
2004-06-02
CRTXHealthcare Ventures VI LP10%C - Converted deriv$0.003,701,3324,058,432-48%$00000
D
2004-06-02
CRTXHealthcare Ventures VI LP10%P - Purchase$7.00+357,1004,058,432+10%+$2,499,7000000
D Derivative transaction exists (usually option exercise)
Open: Yahoo - Finviz - Stockcharts - Google

Return to top
S - SaleSale of securities on an exchange or to another person
S - Sale on exerciseSale of securities on an exchange or to another person (after option exercise)
F - OptEx/tax paymentPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person